Effector Therapeutics Inc Defensive Interval Ratio
Effector Therapeutics Inc defensive interval ratio. Effector Therapeutics Inc (EFTR) has a Defensive Interval Ratio of 141 days as of March 2024. Defensive assets of $9.89 Million (cash $-, short-term investments $9.88 Million, receivables $17.00K) cover 141 days of daily cash needs of $70.05K/day. See working capital position of Effector Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Effector Therapeutics Inc (2021–2023)
Defensive interval ratio of Effector Therapeutics Inc from 2021 to 2023. This chart shows how Effector Therapeutics Inc's Defensive Interval Ratio has evolved across 3 annual periods from 2021 to 2023. As of March 2024, the ratio stands at 141 days, meaning defensive assets of $9.89 Million can fund 141 days of operations without new revenue. Check how resilient are Effector Therapeutics Inc's assets to evaluate the company's liquid asset resilience ratio.
Effector Therapeutics Inc Defensive Interval Ratio by Year (2021–2023)
Effector Therapeutics Inc defensive interval ratio by year from 2021 to 2023. The table below presents the year-by-year Defensive Interval Ratio for Effector Therapeutics Inc from 2021 to 2023, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Effector Therapeutics Inc assets under control.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2023 | 50 days | $3.55 Million | $70.67K/day | $- | $3.50 Million | ▼ -206 days |
| 2022 | 257 days | $17.63 Million | $68.70K/day | $- | $17.60 Million | ▲ +247 days |
| 2021 | 9 days | $100.00K | $10.90K/day | $- | $0.00 | — |